Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Austria

European Research Council grant · Running

Time2SWITCH Bioorthogonal Iontronic Chemistry: Spatiotemporal Drug Release with Electronic Precision

Coordinator
Technische Universitaet Wien, Austria
Runs
1 September 2024 to 31 August 2029
Status
Running
EU funding
€1.5m
Total cost
€1.5m
Partners
1 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101117736

What the project is doing

In the project's own words, from its summary on CORDIS.

I envision a new drug delivery system capable spatiotemporal release with electronic precision. This technology is based on; Biontronic Chemistry (BC) which combines Bioorthogonal Release (BR) and Iontronic transport to overcome the drawbacks of each individual technology and combine their unique advantages. An electronic ion pump (IP) will enable programable electrophoretic transport of chemical triggers without liquid flow or moving mechanical parts to initiate the ultrafast & selective bioorthogonal release (BR) of drugs at the target site to generate previously unobtainable dynamic concentration-time profiles.

Hence, BC translates electrical stimuli, of arbitrary frequencies and amplitudes, into tailor-made bio-chemical concentration/time profiles. By incorporating surface release functionalities and orthogonal bioorthogonal chemistries I will further expand the concept and demonstrate choreographed cascade releases to afford individually programmable release of multiple compounds with distinct concentration/time profiles. We will map out this large parameter space using a combination of rational chemical design, computationally aided device physics and engineering, fluorescent model systems and finally evaluation in cell models.

T2S will lay the foundation for new directions in science and offer unprecedented opportunities for various therapies wherein choreographed, spatiotemporal control of multiple drug release is key (e.g. cancer; nerve regeneration and aging). My hypothesis is that if we combine local drug delivery and chronotherapy, we can dramatically increase treatment efficacy and reduce (if not completely) eliminate side effects. My overarching goal is to create a Switch that elevates medicine to the 5th dimension (5D) thus paving the way towards a paradigm shift in drug delivery and our understanding/ability to manipulate biological-spacetime by delivering the right dose (1D) at the right place (3D) at the right time (1D).

Topics

Who is involved

OrganisationCityCountryRole
Technische Universitaet WienWienAustriaCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI